NPTH 📈 NeuPath Health - Overview
Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA64133P1009
NPTH: Health, Services, Management, Treatment, Assessment, Therapy, Care
NeuPath Health Inc. provides chronic pain management services in Canada. The company offers chronic pain assessment and multi-modal treatment plan that helps patient to manage pain and optimize quality of life. It also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers comprising cardiologists, dentists, dermatologists, endocrinologists, psychiatrists, gastroenterologists, general practitioners, internal medicine specialists, neurologists, neuropsychiatrists, neuropsychologists, occupational therapists, ophthalmologists, orthopedic surgeons, physiatrists, physiotherapists, psychologists, respirologists, and rheumatologists. In addition, the company operates a network of healthcare clinics and related businesses. The company is headquartered in Mississauga, Canada. Web URL: https://www.neupath.com
Additional Sources for NPTH Stock
NPTH Stock Overview
| Market Cap in USD | 7m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
NPTH Stock Ratings
| Growth 5y | -77.4% |
| Fundamental | 24.3% |
| Dividend | - |
| Rel. Strength Industry | -213 |
| Analysts | - |
| Fair Price Momentum | 0.16 CAD |
| Fair Price DCF | 0.85 CAD |
NPTH Dividends
No Dividends PaidNPTH Growth Ratios
| Growth Correlation 3m | 45.1% |
| Growth Correlation 12m | -14.1% |
| Growth Correlation 5y | -77.7% |
| CAGR 5y | -28.80% |
| CAGR/Mean DD 5y | -0.44 |
| Sharpe Ratio 12m | 0.45 |
| Alpha | 4.82 |
| Beta | 0.25 |
| Volatility | 186.99% |
| Current Volume | 19.3k |
| Average Volume 20d | 165.9k |
What is the price of NPTH stocks?
As of December 21, 2024, the stock is trading at CAD 0.20 with a total of 19,300 shares traded.
Over the past week, the price has changed by -2.63%, over one month by +15.62%, over three months by +2.78% and over the past year by -2.63%.
As of December 21, 2024, the stock is trading at CAD 0.20 with a total of 19,300 shares traded.
Over the past week, the price has changed by -2.63%, over one month by +15.62%, over three months by +2.78% and over the past year by -2.63%.
Is NeuPath Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, NeuPath Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 24.34 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NPTH as of December 2024 is 0.16. This means that NPTH is currently overvalued and has a potential downside of -20%.
Neither. Based on ValueRay Fundamental Analyses, NeuPath Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 24.34 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NPTH as of December 2024 is 0.16. This means that NPTH is currently overvalued and has a potential downside of -20%.
Is NPTH a buy, sell or hold?
NeuPath Health has no consensus analysts rating.
NeuPath Health has no consensus analysts rating.
What are the forecast for NPTH stock price target?
According to ValueRays Forecast Model, NPTH NeuPath Health will be worth about 0.2 in December 2025. The stock is currently trading at 0.20. This means that the stock has a potential downside of -15%.
According to ValueRays Forecast Model, NPTH NeuPath Health will be worth about 0.2 in December 2025. The stock is currently trading at 0.20. This means that the stock has a potential downside of -15%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 0.5 | 150% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.2 | -15% |